Contact
Please use this form to send email to PR contact of this press release:
CerSci Therapeutics Announces FDA Notification that First Clinical Trial of Non-Opioid Analgesic for Pain May Proceed
TO:
Lucas Rodriguez
CerSci Therapeutics
+1 2149020484